This activity is provided by Imedex®, LLC.
Supported by educational grants from Pharmacyclics, an AbbView Company and Janssen Biotech, Inc. and TG Therapeutics..
Specialty: Hematology/Oncology, Oncology
Target Audience: This educational activity is designed for US-based hematologists, medical oncologists, hematopathologists, other healthcare professionals interested in the therapeutic management of hematologic malignancies.
All other health care professionals completing this course will be issued a statement of participation.
This series consists of 2 continuing education activities, the links below will be live and take you to activity details and content.
Module 1 – Velocity Vlog: Transforming the Diagnosis and Treatment of Chronic Lymphocytic Leukemia
Module 2 – Whiteboard Update: Transforming the Diagnosis and Treatment of Chronic Lymphocytic Leukemia